Position
Squarepoint Ops LLC in Summit Therapeutics Inc.
Back to the book · All holders of SMMT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $902.4K$17.49 → $18.96
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 715.4K | $12.5M | — | — | — | 0.0% |
| Q1 2026 | 613.9K | $11.6M | $18.96 | $902.4K | −$1.78M | 0.0% |